Podcasts about ulipristal

In this episode, we review the high-yield topic of Mifepristone/Ulipristal⁠ ⁠from the Obstetrics section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets

Episode 129: Emergency ContraceptionBailey describes the available methods of emergency contraception in the United States. Written by Bailey Corona, MS4, American University of the Caribbean. Editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Definition. Emergency contraception refers to therapy used after intercourse to prevent pregnancy. The need for emergency contraception can happen for many reasons, such as a condom breaking or failure to use contraception. More than 11% of sexually active women in the United States between ages 15 and 44 reports using emergency contraception at least once. With such high demand, a multitude of options has become available to meet these needs. With so many options on the market, it may be difficult to decide which option best fits the needs of each individual, which makes it important for providers to have a clear understanding of the risks and benefits associated with each method. Emergency contraception may be commonly used by young patients as their main contraception method. Let's talk about the types of emergency contraception.Levonorgestrel-only (Plan B®).Levonorge'strel-only emergency contraception is the most popular option on the market today. More commonly known as “Plan-B”, this therapy works because of levonorgestrel's similar make-up to progesterone. Mechanism of action.High levels of progesterone delay follicular development so long as it is administered before the level of luteinizing hormone begin to rise. This gives contraceptive therapy of this class a therapeutic window of 72 hours which is the most limited window of all the methods discussed. Despite this shortcoming, Levonorgestrel contraception remains the most popular option because it can be purchased over the counter without the need of a physician and is available to women of all ages. Additionally, therapy includes only a single 1.5mg dose making noncompliance virtually non-existent. Side effects. Side effects include nausea in 12% of patients and headache in 19% of patients. According to one study, 16% of women reported self-resolving uterine bleeding within the first week after use.Selective progesterone modulators (Ella®).The second most commonly used form of emergency contraception are the selective progesterone receptor modulators or more widely known as Ella®. Mechanism of action.Treatment includes a single 30mg dose of ulipristal acetate, which inhibits follicular rupture even after the luteinizing hormone has begun to rise. Due to this mechanism of action, selective progesterone receptor modulators have a wider therapeutic window of 5 days.Side effects.Side effects resemble that of progesterone-only therapy, significant for nausea and headache. Treatment has 2 major barriers preventing it from being the most widely used. Firstly, efficacy is decreased in women with a BMI greater than 35, and secondly, treatment requires a prescription from a medical professional. Estrogen-progesterone combination.Estrogen-progesterone combination therapy is also a viable option for emergency contraception; however, it is no longer available as a dedicated product but can be made from a variety of oral contraceptives. Its decreased popularity is likely due to its increased incidence of nausea when compared to the other options available.Copper IUD.Lastly, Copper IUDs like Paragard can be used for emergency contraception despite not being FDA-approved for this purpose. Copper IUDs are highly effective if placed within 5 days of intercourse, but studies have shown therapy to be effective up to 10 days after. Mechanism of action.Copper IUDs prevent fertilization by altering sperm viability and oocyte-endometrium interaction. This method is the most invasive as it requires placement by a physician and carries the rare risk of uterine perforation, occurring in around 1/1000 IUD placements. That said, copper IUD placement carries with it the added benefit of continued contraception for 10 years. It is contraindicated, however, in patients with a history of heavy menstrual bleeding. FAQs about emergency contraception:Does increasing the availability of emergency contraception encourage risky sexual behavior?No, according to a systematic review by Maria Rodrigues, there was no significant increase in sexually risky behavior correlated with increased availability of emergency contraception.Rodriguez MI, et al.What is the greatest barrier to emergency contraception use in the United States?Education. A study by Abbott J, et al, interviewed adolescents receiving care in urban emergency rooms. The study showed that only 64% of patients had ever heard of emergency contraception. By educating patients of reproductive age on what options may be available to them it is expected that there would be a decrease in unplanned pregnancies. Additionally, studies like “knowledge of emergency contraception among women aged 18-44 in California” by Foster DG have gone further to establish that women of lower socioeconomic status, foreign birth, or who have not graduated high school also have suboptimal education in emergency contraception.When should someone use emergency contraception?Treatment should begin as soon as possible after unprotected intercourse in order to ensure maximum efficacy. 3 days for Plan B, 5 days for Ella, and 10 days for IUD.How effective is emergency contraception?The answer to this question differs based upon what method a patient decides to useIUDsA systematic review of 42 studies over a 35-year time period reports that pregnancy rates were between 0 and 2%.The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience by Cleland K. et al. Oral regimens have been studied extensively and have shown that ulipristal acetate like Ella® are slightly more effective, showing a pregnancy rate of 1.4% and a rate of 2.2% in levonorgestrel-only pills like Plan B. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta-analysis by Glacier AF.Do patients require follow up after use of emergency contraception?No. Only if there is a delay in the start of normal menses by greater than 1 week or if lower abdominal pain or persistent irregular bleeding develops.___________________Conclusion: Now we conclude episode number 129 “Emergency Contraception.” Bailey explained that a pelvic exam is not needed in most cases before or after emergency contraception. Plan B® is available over the counter, while Ella® is available with a prescription. Copper IUD is not FDA-approved for emergency contraception, but evidence has shown it is an effective method. Dr. Arreaza suggested that, after learning more about emergency contraception, listeners can draw their own conclusions about the ethical dilemma of prescribing it to their patients. This week we thank Hector Arreaza and Bailey Corona. Audio editing by Adrianne Silva.Even without trying, every night, you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you; send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! ____________________Sources:Abbott J, Feldhaus KM, Houry D, Lowenstein SR. Emergency contraception: what do our patients know? Ann Emerg Med. 2004 Mar;43(3):376-81. doi: 10.1016/S019606440301120X. PMID: 14985666. https://pubmed.ncbi.nlm.nih.gov/14985666/.Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012 Jul;27(7):1994-2000. doi: 10.1093/humrep/des140. Epub 2012 May 8. PMID: 22570193; PMCID: PMC3619968. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619968/.“Emergency Contraception.” ACOG, https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2015/09/emergency-contraception.Foster DG, Harper CC, Bley JJ, Mikanda JJ, Induni M, Saviano EC, Stewart FH. Knowledge of emergency contraception among women aged 18 to 44 in California. Am J Obstet Gynecol. 2004 Jul;191(1):150-6. doi: 10.1016/j.ajog.2004.01.004. PMID: 15295356. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619968/Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010 Feb 13;375(9714):555-62. doi: 10.1016/S0140-6736(10)60101-8. Epub 2010 Jan 29. Erratum in: Lancet. 2014 Oct 25;384(9953):1504. PMID: 20116841.https://pubmed.ncbi.nlm.nih.gov/20116841/Jayson, Sharon. “5.8M Women Have Used 'Morning after' Pill.” USA Today, Gannett Satellite Information Network, 14 Feb. 2013, https://www.usatoday.com/story/news/nation/2013/02/13/cdc-contraception-emergency-methods/1914673/. Rodriguez MI, Curtis KM, Gaffield ML, Jackson E, Kapp N. Advance supply of emergency contraception: a systematic review. Contraception. 2013 May;87(5):590-601. doi: 10.1016/j.contraception.2012.09.011. Epub 2012 Oct 4. PMID: 23040139. https://pubmed.ncbi.nlm.nih.gov/23040139/.von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, Ng E, Gemzell-Danielsson K, Oyunbileg A, Wu S, Cheng W, Lüdicke F, Pretnar-Darovec A, Kirkman R, Mittal S, Khomassuridze A, Apter D, Peregoudov A; WHO Research Group on Post-ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002 Dec 7;360(9348):1803-10. doi: 10.1016/S0140-6736(02)11767-3. PMID: 12480356. https://pubmed.ncbi.nlm.nih.gov/12480356/.Royalty-free music used for this episode: “Gushito - Burn Flow." Downloaded on October 13, 2022, from https://www.videvo.net/

Dr. Donna Harrison is a physician, board-certified in obstetrics and gynecology.  She is currently serving as Chief Executive Officer of the American Association of Pro-Life Obstetricians and Gynecologists, the largest non-sectarian pro-life physician organization in the world, with over 6000 members across the United States, and associate members on every continent. Under her leadership, AAPLOG has doubled membership, launched the annual Matthew Bulfin Educational Conference, developed an up-to-date website and social media presence, and launched systematic outreaches to the medical, legal and policy communities to discuss the effects of abortion on women. Dr. Harrison has authored peer reviewed papers on maternal mortality, mifeprex abortion mortality and morbidity, the approval of RU-486 and Ulipristal (Ella) as well as other topics concerning endometrial contraception. Dr. Harrison is a Continuing Medical Education Speaker in the U.S. and internationally on topics of Medical Abortion with Mifepristone and Misoprostol, Adverse Events associated with Mifepristone and Misoprostol, Emergency Contraception with Ulipristal, Maternal Mortality, and Abortion Morbidity. She is an Adjunct Professor at Trinity International University in Deerfield, IL, teaching post graduate seminars at the annual Center for Bio Ethics and Human Dignity summer workshops. She is Associate Editor of the peer reviewed medical journal “Issues in Law and Medicine.” Dr. Harrison is married to a fellow physician and is the mother of 5 children and 5 grandchildren

  Vidcast:  https://youtu.be/wCUz9n6QOkQ   Even a double dose of Plan B, levonorgestrel, the most common morning after pill, fails to significantly reduce the chances of ovulation and therefore pregnancy in obese women.  Oregon Health and Science University investigators studied 70 women with a mean age of 28, a mean body mass index of 38, and a body weight of greater than 175 pounds.   The group of participants receiving the standard 1.5 mg dose of the progesterone levonorgestrel experienced only a 51% incidence of ovulation prevention while the group receiving the 3 mg double dose had only a 69% ovulation prevention.  Not every effective.  While the higher dose did inhibit egg release somewhat, the extra protection it afforded was not statistically significant and did not provide reliable emergency contraceptionS.   The OBGYN clinicians participating in the study recommend that obese women requiring emergency contraception consider asking their medical teams for ulipristal, marketed as Ella and EllaOne.  This drug is a selective progesterone receptor modulator and does work effectively in heavier women.   https://journals.lww.com/greenjournal/fulltext/2022/07000/double_dosing_levonorgestrel_based_emergency.8.aspx   #morningafterpill #obesity #ovulation #planB #levonorgestrel #Ella #ulipristal  

Over the last several days I have received numerous Facebook messages, podcast voice memos, and personal texts regarding the potential for misapplication of Ulipristal's mechanism of action as emergency contraception. Will Ella be banned? Does it affect implantation? It's time to clear the dust and set the record straight.

¿Cómo funciona la anticoncepción de emergencia? ¿En qué casos se puede usar? En el episodio de hoy la Dra. Azul Torres

Welcome to our newest series – The Floor Is Yours...where we hand over the show to our GUEST and let them lead us in discussion on a current life issue. These guests are experts in their fields, have a passion for life and the Gospel, and could essentially have their own show! For our first installment, we have a beloved friend, Dr. Donna Harrison, a highly-respected physician and long-standing CEO of AAPLOG (American Association of Pro-Life Obstetricians and Gynecologists). Dr. Harrison uses this episode to bring Steph up to speed on the legal history of abortion in America, starting at Roe v. Wade and leading up to Dobbs v. Jackson. She shares the foreseeable impact of overturning Roe v. Wade through the Dobbs case and the likely effects of federal abortion restrictions. Most notably, Dr. Harrison speaks from her years of medical experience and research in regards to the lasting harm of abortion on men, women, and children and calls the Church to model mercy and care for the men, women, and children vulnerable to abortion. Bio: Dr. Donna Harrison is a physician, board-certified in obstetrics and gynecology. She completed an Honors Bachelor's degree in Biochemistry and Chemistry at Michigan State University and an M.D. from University of Michigan. She completed her residency training in obstetrics and gynecology from St. Joseph Mercy Hospital, an affiliate of University of Michigan. She was in private practice for 10 years. She serves as CEO of the American Association of Pro-Life Obstetricians and Gynecologists, AAPLOG, and has been active with the organization since 1996. AAPLOG is the largest non- sectarian pro-life physician organization in the world, with over 7,000 members across the U.S., and international members on every continent. Under her leadership, AAPLOG has tripled membership, launched the annual Matthew Bulfin Educational Conference, developed a robust website and social media presence, and launched systematic outreaches to the medical, legal and policy communities to discuss the effects of abortion on women. Dr. Harrison's research interests include Selective Progesterone Receptor Modulators, Endometrial Contraception, Maternal Mortality, and Abortion Mortality and Morbidity. She has authored numerous peer reviewed papers on many topics including the approval of RU-486 and on Ulipristal (Ella) as well as on the embryocidal potential of hormonal contraception. Dr. Harrison is a sought after Continuing Medical Education (CME) speaker in the U.S. and internationally on topics of Medical Abortion with Mifepristone and Misoprostol, Adverse Events associated with Mifepristone and Misoprostol, Emergency Contraception with Ulipristal, Maternal Mortality, and Abortion Morbidity. She is an Adjunct Professor at Trinity International University in Deerfield, IL, teaching post graduate seminars at the annual Center for Bio Ethics and Human Dignity summer workshops. She is Associate Editor of the peer reviewed medical journal Issues in Law and Medicine. Dr. Harrison is married to Dr. Mark Harrison M.D. and is the mother of five children and 10 grandchildren. She resides in Michigan. Learn about LCMS Life Ministry at lcms.org/life, and email us at friendsforlife@lcms.org. Not all the views expressed are necessarily those of the LCMS; please discuss any questions with your pastor.

Verhütungspannen können passieren. Wie die „Pille danach“ wirkt und Informationen zur Einnahme erfahren Sie in diesem Podcastbeitrag.

Con la Determina n. 998 dell’8 Ottobre, l’Aifa ha eliminato la prescrizione anche se a richiedere l’Ulipristal acetato sono delle minorenni. Questo, oltre ai problemi bioetici legati al meccanismo d’azione di EllaOne, dà uno “schiaffo morale” a una serie di dimensioni umane e relazioni che vi si trovano coinvolte.

Buenos días a todos! Hoy os traigo la alerta sanitaria relacionada con la retirada del Esmya, os hago una pequeña crítica de cómo estas alertas de suspensión de tratamiento y comercialización nunca vienen de nuevas, se sabía desde hacía 2 años aproximadamente sus posibles problemas y os comento si se ve afectado EllaOne al llevar el mismo principio activo, de paso repasamos cómo actúa. Espero que os guste!!

Heute geht es um ein regelmäßiges Apotheken-Notdienst-Thema, die Pille danach (oder im Englischen die “Morning After Pill”)  //   Ein wichtiges ThemaDeutschlandweit ca. 2,4 Millionen Verhütungspannen im Jahr. Weltweit werden jedes Jahr fast 100 Millionen Frauen ungewollt schwanger. Anteil der ungewollten an allen Schwangerschaften 44 % (Bearak et al. 2018). Mehr als die Hälfte der ungewollten Schwangerschaften werden vorzeitig beendet. Bei rechtzeitiger und richtiger Einnahme können Notfallpillen den Eisprung verschieben und zu ca. 98% eine ungewollte Schwangerschaft verhindern. Was tun? Nur Pille vergessen?Bis zu 12 h, einfach verspätet nehmen Die nächste wieder im normalen Rhythmus Bsp.: Normal immer 22:00 Uhr, vergessen, bis 10:00 Uhr am nächsten Tag OK, dann wieder 22:00 Uhr Ausnahme alte Minipille, hier nur 3 h Verspätung möglich, d.h. spätestens 01:00 Uhr Wann gleich zum Arzt?≤14 J Letzte Periode nicht planmäßig, nicht normal, länger als 28 Tage Oder schon vorher im selben Zyklus ungeschützten GV Oder schon vorher im selben Zyklus Pille danach genommen (--> Verdacht auf schon bestehende Schwangerschaft) In allen anderen Fällen zur Apotheke Für 100% die “Spirale danach”Kupfer, nicht Hormonspiralen Bis 5 Tage danach VorteilPillen verhindern Eisprung, Spirale Einnistung des befruchteten Ei NachteileWesentlich teurer Schmerzhaft wenn Muttermund nicht geöffnet wie während der Periode https://www.familienplanung.de/verhuetung/verhuetungspannen/spirale-danach/ Pille(n) danachseit 2015 nicht mehr Rezept-pflichtig = selber zahlen Ausnahme: bis einschl. 22 J + ärztlich verordnet Ab 18 J auch bei Rezept noch Zuzahlung zahlen Zwei Wirkstoffe In der Apotheke + nach entsprechender diskreter Beratung (2017: 808.000 mal): Levo-Norgestrel (LNG), z.B. PiDaNa® und Generika wie Unofem® oder Levonoraristo® Ulipristal-Acetat (UPA), Progesteronrezeptormodulator, z. B. ellaOne® Wie wirkt die Pille danach? Der normale EisprungWenn Luteinisierende Hormon (LH) höchste Konzentration. LH-Anstieg ca. 2 Tage vor dem Eisprung fruchtbarste Zeit / höchstes Risiko Zyklus 14+14 Tage Diese Phase aber variabel. Zeitpunkt des Eisprungs nicht vorhersag- oder berechenbar. 14. Tag des Zyklus:

Welcome back to Six Minute Sex Ed, the podcast that helps families talk about sex and relationships, hosted by Sex Education teacher, Kim Cavill: https://www.teaandintimacy.com/ This episode is Level Two, which makes it more complex than my level one episodes and especially great for tweens and teens. We’re going to talk about Emergency Contraception. What is it? Emergency contraception is birth control taken up to five days after risky sex in order to prevent pregnancy. There are three kinds: two pills and the copper IUD. How does it work? Levonelle prevents ovulation, Ulipristal blocks the body’s own hormones, and the Copper IUD prevents sperm from reaching the egg. See a copper IUD here: http://teenhealthsource.com/birthcontrol/copper-iud-details/ How Effective is it? Levonelle is 95% effective in the first 12 hours after risky/unprotected sex, then steadily drops in efficacy (85% after 48 hours, 58% after 72 hours). Ullipristal is 95% effective for five days after risky/unprotected sex. The Copper IUD is 99.9% effective for five days after risky/unprotected sex, making it the most effective form of EC available. Side effects: All three interventions are very safe and side effects are very rare, though they include irregular bleeding, upset stomach, and headaches. Some medical conditions make EC unsafe to take, so it’s important to speak to a doctor to check it’s safe: if you can’t reach your doctor, text “PPNOW" to 774636 (PPINFO) text with someone from Planned Parenthood who can help. Side effects of the copper IUD include temporary cramping, spotting, and heavier or more painful periods. Tips: Because levonelle is time sensitive, it’s a good idea to have a dose on hand, before it’s actually needed, just make sure it’s available. You can also use some forms of the birth control pill as emergency contraception, but ONLY if taken according to very specific guidelines and it’s less effective than the other options I’ve talked about, so make sure to speak to a doctor before trying this method. Know your rights by educating yourself about the laws in your state: https://www.guttmacher.org/state-policy/explore/emergency-contraception For more info about emergency contraception, check out: http://www.scarleteen.com/article/sexual_health/emergency_contraception?language=es Conversation starters: What are the state laws about emergency contraception where you live? Why is it a good idea to have a dose on hand before it’s actually needed? Email questions for the upcoming mailbag episode to sixminutesexed@gmail.com

The etonogestrel contraceptive implant is a type of LARC with proven high efficacy. Yet, similar to all progestin only contraception, abnormal bleeding can become bothersome to the patient- especially in the first 3 to 6 months of use. Ulipristal, a progesterone receptor modulator, has shown promise as a new medical agent to help relieve bothersome bleeding in these patients. In this podcast, we will review the latest data from a randomized controlled trial (Oct 2018) on ulipristal for bleeding control in Nexplanon users.

Pharmapills - Pillole dal farmaceuticoNovità, Curiosità e Lavoro dal mondo del Farmaceutico. A cura di Stefano Lagravinese.In questa puntata parliamo di:Aziende: Astrazeneca, AbbVie, Angelini, Bayer, GSK, Laboratori Abbott, Amgen, Pfizer, Novartis, Roche, Eli Lilly, Johnson & Johnson, Recordati, Fidia Farmaceutici, Therabel, Mediolanum Farmaceutici e Ifom.Persone: Fabrizio Greco (AbbVie Italia), Egiziano Iencinella (Angelini), Amelia Parente (Roche), Jean-Michel Robert (Therabel), Valter Longo (Ifom) e Massimo Scaccabarozzi (Farmindustria).Nuove terapie: Evolocumab, Ulipristal acetato e Rivaroxaban.Patologie: cirrosi epatica, fibrosi polmonare, diabete, osteoporosi, artrite, progeria, fibromi uterini, coronaropatia o arteriopatia periferica, amiloidosi, porfiria ed emofilia.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Per approfondire gli argomenti visita il sito web www.PharmaPills.it e clicca mi piace sulla pagina facebook “PharmaPills”. Ricevi ulteriori informazioni e nuovi contenuti in tempo reale tramite il canale telegram www.telegram.me/pharmapills.Gli autori:- Linda Scannavini (speaker)- Giorgia Latteri (montaggio)- Stefano Lagravinese (regia e cordinamento)Contatto diretto: pharmapills [chiocciolina] carrieranelfarmaceutico.com

Pharmapills - Pillole dal farmaceuticoNovità, Curiosità e Lavoro dal mondo del Farmaceutico. A cura di Stefano Lagravinese.In questa puntata parliamo di:Aziende: Astrazeneca, AbbVie, Angelini, Bayer, GSK, Laboratori Abbott, Amgen, Pfizer, Novartis, Roche, Eli Lilly, Johnson & Johnson, Recordati, Fidia Farmaceutici, Therabel, Mediolanum Farmaceutici e Ifom.Persone: Fabrizio Greco (AbbVie Italia), Egiziano Iencinella (Angelini), Amelia Parente (Roche), Jean-Michel Robert (Therabel), Valter Longo (Ifom) e Massimo Scaccabarozzi (Farmindustria).Nuove terapie: Evolocumab, Ulipristal acetato e Rivaroxaban.Patologie: cirrosi epatica, fibrosi polmonare, diabete, osteoporosi, artrite, progeria, fibromi uterini, coronaropatia o arteriopatia periferica, amiloidosi, porfiria ed emofilia.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Per approfondire gli argomenti visita il sito web www.PharmaPills.it e clicca mi piace sulla pagina facebook “PharmaPills”. Ricevi ulteriori informazioni e nuovi contenuti in tempo reale tramite il canale telegram www.telegram.me/pharmapills.Gli autori:- Linda Scannavini (speaker)- Giorgia Latteri (montaggio)- Stefano Lagravinese (regia e cordinamento)Contatto diretto: pharmapills [chiocciolina] carrieranelfarmaceutico.com

Esmya puede disminuir el tamaño de los fibromas antes de una cirugía o incluso, en algunos casos, hacer que no sea necesario intervenir quirúrgicamente.

Il ulipristal acetato (Esmya) può essere una buona opzione per le donne con fibromi uterini e che desiderano una gravidanza. Traduzione:Elisabetta Ricciarelli Musica:Emilio Estebanhttps://open.spotify.com/track/3FMPu7HNk6SRRNM7N7mN2A

Il ulipristal acetato (Esmya) può essere una buona opzione per le donne con fibromi uterini e che desiderano una gravidanza. Traduzione:Elisabetta Ricciarelli Musica:Emilio Estebanhttps://open.spotify.com/track/3FMPu7HNk6SRRNM7N7mN2A

A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Mixtard 30 - going, going, gone?Ulipristal – a new emergency contraceptive pillManagement of fibromyalgiaAgomelatine for major depressive episodes